Trevena (NASDAQ:TRVN) Coverage Initiated at StockNews.com
Equities researchers at StockNews.com assumed coverage on shares of Trevena (NASDAQ:TRVN – Get Free Report) in a note issued to investors on Wednesday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Trevena Price Performance Shares of NASDAQ:TRVN opened at $1.24 on Wednesday. Trevena has a 1 year low of $0.95 and a […]
